Neuropsychological Functioning in Patients with Post Traumatic Stress Disorder Following Short Term Paroxetine Treatment
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
A previous study found improvements in verbal declarative memory in patients with Posttraumatic Stress Disorder (PTSD) following one year of open-label paroxetine treatment. The purpose of the present study was to replicate prior findings and to extend the previous study by comparing the effects of paroxetine versus placebo on cognition in patients with PTSD. Methods: Eighteen participants with PTSD underwent assessment of neuropsychological function, following which they were randomized to receive controlled-release (CR) paroxetine or placebo, given in a variable dose in a double-blind manner for three months. Neuropsychological testing was then repeated. Subjects who had received placebo were then treated with open-label paroxetine CR and re-assessed. Results: Paroxetine CR treatment resulted in a significant increase in verbal declarative memory function in the group as a whole, as measured by the Wechsler Memory Scale-Revised, the Selective Reminding Test, and novel paragraph recall, and explicit recall of neutral words. Although we found patterns of improved test performance with paroxetine versus placebo treatment, these differences were not statistically significant. Conclusion: These findings replicate an earlier finding that open-label treatment with paroxetine CR is associated with improvements in verbal declarative memory function. The current study did not show a statistically significant difference between the effects of paroxetine and placebo on memory function, which may in part be related to our small sample size. Psychopharmacology Bulletin. 2009;42(1):53–68.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.7.973 · Cited by 1,610 · cited 1×
“Although seven participants had endured multiple life trauma, the most frequently reported primary trauma was childhood sexual abuse (8) followed by adult physical (4) and sexual assault (3), and childhood physical abuse (2), combat (1), and witnessing trauma (1).”
BackgroundSelf-citationBremner, J. D., Randall, P., Vermetten, E., Staib, L., Bronen, R. A., Mazure, C., Capelli, S., McCarthy, G., Innis, R. B., & Charney, D. S. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00162-x · Cited by 1,283
Self-citationPTSD in Urban Primary Care: High Prevalence and Low Physician Recognition
Liebschutz, J., Saitz, R., Brower, V., Keane, T. M., Lloyd-Travaglini, C., Averbuch, T., & Samet, J. H. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-007-0161-0 · Cited by 223 · cited 1×
“Although seven participants had endured multiple life trauma, the most frequently reported primary trauma was childhood sexual abuse (8) followed by adult physical (4) and sexual assault (3), and childhood physical abuse (2), combat (1), and witnessing trauma (1).”
Background
Cited by
Executive function and PTSD: disengaging from trauma.
Aupperle, R. L., Melrose, A. J., Stein, M. B., & Paulus, M. P. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.02.008 · Cited by 657
“(Fani et al., 2009) used a double-blind, placebo-controlled design and reported paroxetine treatment to be associated with a non-significant trend toward improved verbal declarative memory.”
A quantitative meta-analysis of neurocognitive functioning in posttraumatic stress disorder.
Scott, J. C., Matt, G. E., Wrocklage, K. M., Crnich, C., Jordan, J., Southwick, S. M., Krystal, J. H., & Schweinsburg, B. C. (2015) · Psychological Bulletin · doi:10.1037/a0038039 · Cited by 513
“In contrast, evidence from two longitudinal studies has shown that treatment with the selective serotonin reuptake inhib itor paroxetine not only reduces PTSD symptom severity but also increases hippocampal volume and improves verbal memory (Fani et al., 2009; Vermetten, Vythilingam, Southwick, Chamey, & Bremner, 200…”
ResultLee, D. J., Schnitzlein, C. W., Wolf, J. P., Vythilingam, M., Rasmusson, A. M., & Hoge, C. W. (2016) · Depression and Anxiety · doi:10.1002/da.22511 · Cited by 416
Bandelow, B., Baldwin, D., Abelli, M., Bolea-Alamanac, B., Bourin, M., Chamberlain, S. R., Cinosi, E., Davies, S., Domschke, K., Fineberg, N., et al. (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2016.1190867 · Cited by 347
“18 PTSD patients, treatment with the SSRI paroxetine resulted in a significant increase in verbal declarative memory function (Fani et al. 2009).”
BackgroundPrado, C. E., Watt, S., & Crowe, S. F. (2018) · Neuropsychology Review · doi:10.1007/s11065-018-9369-5 · Cited by 188
Metadata
- Authors
- Fani, N., Kitayama, N., Ashraf, A., Reed, L., Afzal, N., Jawed, F., & Bremner, J. D.
- Venue
- Psychopharmacology Bulletin
- Publisher
- Medworks Media Inc.
- Published
- 2025-08-12
- Volume
- 42
- Issue
- 1
- Pages
- 53-68
- ISSN
- 0048-5764 (ISSN-L)
- 2472-2448
- OpenAlex
- W4415380253
- Cited by
- 27
- References
- 3
- FWCI
- 1.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.